Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study
- PMID: 23258810
- PMCID: PMC3526982
- DOI: 10.1093/ndt/gfs544
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study
Abstract
Background: To describe the causes of graft loss, patient death and survival figures in kidney transplant patients in Spain based on the recipient's age.
Methods: The results at 5 years of post-transplant cardiovascular disease (CVD) patients, taken from a database on CVD, were prospectively analysed, i.e. a total of 2600 transplanted patients during 2000-2002 in 14 Spanish renal transplant units, most of them receiving their organ from cadaver donors. Patients were grouped according to the recipient's age: Group A: <40 years, Group B: 40-60 years and Group C: >60 years. The most frequent immunosuppressive regimen included tacrolimus, mycophenolate mofetil and steroids.
Results: Patients were distributed as follows: 25.85% in Group A (>40 years), 50.9% in Group B (40-60 years) and 23.19% in Group C (>60). The 5-year survival for the different age groups was 97.4, 90.8 and 77.7%, respectively. Death-censored graft survival was 88, 84.2 and 79.1%, respectively, and non death-censored graft survival was 82.1, 80.3 and 64.7%, respectively. Across all age groups, CVD and infections were the most frequent cause of death. The main causes of graft loss were chronic allograft dysfunction in patients <40 years old and death with functioning graft in the two remaining groups. In the multivariate analysis for graft survival, only elevated creatinine levels and proteinuria >1 g at 6 months post-transplantation were statistically significant in the three age groups. The patient survival multivariate analysis did not achieve a statistically significant common factor in the three age groups.
Conclusions: Five-year results show an excellent recipient survival and graft survival, especially in the youngest age group. Death with functioning graft is the leading cause of graft loss in patients >40 years. Early improvement of renal function and proteinuria together with strict control of cardiovascular risk factors are mandatory.
Figures
Similar articles
-
Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease.Kidney Int Suppl. 2008 Dec;(111):S94-9. doi: 10.1038/ki.2008.547. Kidney Int Suppl. 2008. PMID: 19034336
-
Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.Exp Clin Transplant. 2010 Dec;8(4):277-82. Exp Clin Transplant. 2010. PMID: 21143092
-
[Delayed graft function and its impact on the antigraft response after cadaver kidney transplantation].Medicina (Kaunas). 2005;41 Suppl 1:101-6. Medicina (Kaunas). 2005. PMID: 15901985 Lithuanian.
-
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210. Health Technol Assess. 2005. PMID: 15899149 Review.
-
Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?Paediatr Drugs. 2011 Feb 1;13(1):49-69. doi: 10.2165/11538530-000000000-00000. Paediatr Drugs. 2011. PMID: 21162600 Review.
Cited by
-
Debiased lasso for stratified Cox models with application to the national kidney transplant data.Ann Appl Stat. 2023 Dec;17(4):3550-3569. doi: 10.1214/23-aoas1775. Epub 2023 Oct 30. Ann Appl Stat. 2023. PMID: 38106966
-
The impact of diabetes and hypertension on renal allograft survival- A single center study.Curr Urol. 2023 Dec;17(4):286-291. doi: 10.1097/CU9.0000000000000068. Epub 2022 Aug 2. Curr Urol. 2023. PMID: 37994332 Free PMC article.
-
Outcomes in older kidney recipients from older donors: A propensity score analysis.Front Nephrol. 2022 Oct 20;2:1034182. doi: 10.3389/fneph.2022.1034182. eCollection 2022. Front Nephrol. 2022. PMID: 37675023 Free PMC article.
-
Comorbid Conditions in Kidney Transplantation: Outcome Analysis at King Abdulaziz Medical City.Cureus. 2023 Jul 4;15(7):e41355. doi: 10.7759/cureus.41355. eCollection 2023 Jul. Cureus. 2023. PMID: 37546132 Free PMC article.
-
Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.PLoS One. 2022 Jul 14;17(7):e0269990. doi: 10.1371/journal.pone.0269990. eCollection 2022. PLoS One. 2022. PMID: 35834500 Free PMC article.
References
-
- Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002;346:580. - PubMed
-
- Woodroffe R, Yao GL, Meads C, et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation. A systematic review and modelling study. Health Technol Assess. 2005;9:1. - PubMed
-
- Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1998 to 1996. N Engl J Med. 2000;342:605. - PubMed
-
- Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease of acute rejection rates over the most recent era. Am J Transplant. 2004;4:378. - PubMed
-
- Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):112–119. - PubMed
